What are the indications for Ruxolitinib Tablets/Jiekewei?

Ruxolitinib tablets/Ruxolitinib (Ruxolitinib) is a JAK inhibitor that mainly regulates abnormal responses of the immune system by inhibiting the Janus kinase (JAK) signaling pathway. It has been approved for the treatment of a series of diseases caused by immune system disorders. It is an effective drug in the treatment of diseases such as myelofibrosis, polycythemia vera, and **graft-versus-host disease (GVHD)**.

1. Myelofibrosis is a chronic bone marrow disease in which the patient's bone marrow is replaced by fibrous tissue, resulting in limited blood cell production, which may cause serious problems such as anemia, infection, and bleeding. Ruxolitinib improves bone marrow function and restores blood cell production by inhibiting the excessive activity of JAK2, thereby effectively controlling the progression of myelofibrosis and alleviating related symptoms.

2. Polycythemia Vera (PV) is a blood disease caused by an excess of red blood cells. It is usually accompanied by an increase in blood viscosity and increases the risk of thrombosis. Ruxolitinib reduces the abnormal increase in red blood cells, improves the patient's blood circulation, reduces the risk of thrombosis, and improves the patient's quality of life by inhibiting the signaling pathway related to JAK2 mutations.

3. Ruxolitinib is also used to treat graft-versus-host disease (GVHD), which is a common post-transplantation complication that occurs after bone marrow or other organ transplants. The immune cells in the transplant attack the host's normal tissues. Ruxolitinib reduces the symptoms of GVHD and helps patients control immune rejection by regulating the excessive response of the immune system.

In short, ruxolitinib can effectively treat a variety of diseases caused by immune system or bone marrow abnormalities by acting on theJAK-STAT signaling pathway. It is especially suitable for patients with myelofibrosis, polycythemia vera and graft-versus-host disease.

Reference materials:https://www.jakavi.com/